Phospho-CD318 (Y707) Polyclonal Antibody

CDCP1 (CUB domain containing protein 1) encodes a transmembrane protein which contains three extracellular CUB domains and acts as a substrate for Src family kinases. The protein plays a role in the tyrosine phosphorylation-dependent regulation of cellular events that are involved in tumor invasion and metastasis. Alternative splicing results in multiple transcript variants of CDCP1.

Introducing the Phospho-CD318 (Y707) Polyclonal Antibody, a cutting-edge scientific tool meticulously designed to facilitate advanced research in the field of molecular biology. This antibody, derived from a polyclonal source, exhibits exceptional specificity and sensitivity, enabling precise detection and analysis of phosphorylated CD318 at the tyrosine 707 residue.

Crafted with utmost precision and utilizing state-of-the-art technology, this antibody offers researchers an invaluable resource for investigating the intricate signaling pathways involving CD318. Its unique ability to recognize and bind specifically to the phosphorylated form of CD318 at the Y707 site empowers scientists to delve deeper into the functional implications of this post-translational modification.

The Phospho-CD318 (Y707) Polyclonal Antibody boasts an impressive range of applications, including but not limited to immunoblotting, immunoprecipitation, and immunofluorescence. Its versatility allows for comprehensive exploration of CD318 phosphorylation dynamics across various experimental setups, facilitating a comprehensive understanding of its role in cellular processes.

Furthermore, this antibody has been rigorously validated through meticulous quality control measures to ensure consistent and reliable performance. Its exceptional specificity guarantees minimal cross-reactivity with non-phosphorylated CD318 or other proteins, thereby enhancing the accuracy and reliability of experimental results.

In summary, the Phospho-CD318 (Y707) Polyclonal Antibody represents a breakthrough in molecular biology research, offering scientists an indispensable tool for investigating the intricate world of CD318 phosphorylation. With its unparalleled specificity, sensitivity, and versatility, this antibody is poised to revolutionize the understanding of CD318 signaling pathways and contribute to advancements in various fields, including cancer research, cell biology, and drug discovery.